BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …

Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of
the current management of chronic obstructive pulmonary disease (COPD) and are critical in …

Bronchodilators are the cornerstone of pharmacological management of COPD. For patients
whose conditions are not sufficiently controlled by monotherapy, combining bronchodilators …

Background Combining two long-acting bronchodilators with complementary mechanisms of
action may provide treatment benefits to patients with chronic obstructive pulmonary disease …

This study compared the bronchodilator effects of tiotropium, formoterol and both combined
in chronic obstructive pulmonary disease (COPD). A total of 71 COPD patients (mean forced …

Although long-acting bronchodilators have been an important advance for the management
of chronic obstructive pulmonary disease (COPD), these drugs do not deal with the …

慢性阻塞性肺疾病(COPD) 是一种慢性呼吸系统疾病, 其主要特征为肺功能的缓慢减退及进行性
气流受限, 气流受限不完全可逆. 通过积极的预防和治疗可以有效缓解症状, 提高运动耐量 …

Background The combination of short-acting β 2-agonists and anticholinergics in the
treatment of COPD has been well documented, but data on combination of long-acting …

The ritual of routine visits for most chronic diseases usually includes monitoring to check on
the progress or regress of the disease and the development of complications. Such checks …

Chronic obstructive pulmonary disease (COPD) represents a significant cause of global
morbidity and mortality, with a substantial economic impact. Recent changes in the Global …